Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Jan 7, 2028 (in 495 days)
Similar opportunities open now
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2027
- Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jul 2028
Classification and identifiers
- Solicitation number
- PAR-25-143
- Assistance listing (CFDA)
- 93.279
Amount
Amount not published by the funder
Who can apply
Small businesses and Local government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.All applications must be within the scope of the mission of one of the Institutes/Centers listed above.